Bluebomber6 wrote: jojomarch wrote: Who and when are the questions . The when is easy ; very soon because TLT needs capital funding for the multiple indications trials it will do . The who is harder ; I will put my bet on MERCK . Other guesses are more than welcomed as we wait for the inevitable.
GO TLT GO
GO AM GO
GO JV GO
GO MERCK GO
GLTA
The who is very tuff question as is how much!!!
The beauty of a bidding war is that beauty is in the eye of the beholder. And no one knows what pharma beholds and what they would be willing to bid in a sealed bid process.
TLT is in such a unique, revolutionary position, with so many possibilities in so many areas of research, that the successful jv will have to have a wide scope of research capabilities to encompass all the possibilities that TLT offers.
Multiple cancer treatments, depression, alzheimers, dementia, pain relief and more, where does a major pharma begin to evaluate and put a dollar amount?
Not a clue what we are worth! But, bankers are like used car salesmen, they give you pennies on the dollar if you are seeking money! We dont want pennies, we have had pennies for 24 years. Time for the dollars, time for pharma to stop kickin the tires, time for our ceo to say here is the mona lisa of research, what are your bids?